Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranjithkumar Rajendran

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Brain Pathology (Zurich, Switzerland)|January 25, 2017
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylationRanjithkumar Rajendran, Mario Giraldo-Velásquez, Christine Stadelmann, et al.
Cells|April 30, 2021
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease ModelsRanjithkumar Rajendran, Gregor Böttiger, Christine Stadelmann, et al.
Journal of Clinical Medicine|August 7, 2021
Evidence of a Muscle-Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and SerumMartin Berghoff, Alexandra Höpfinger, Ranjithkumar Rajendran, et al.
Brain Pathology (Zurich, Switzerland)|October 26, 2020
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG<sub>35-55</sub> -induced EAE through ERK and Akt signallingSalar Kamali, Ranjithkumar Rajendran, Christine Stadelmann, et al.
International Journal of Molecular Sciences|October 27, 2022
Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune EncephalomyelitisRanjithkumar Rajendran, Vinothkumar Rajendran, Liza Gupta, et al.
Cells|June 2, 2021
Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 OligodendrocytesRanjithkumar Rajendran, Gregor Böttiger, Niklas Dentzien, et al.
International Journal of Molecular Sciences|September 10, 2021
Oligodendrocyte-Specific Deletion of <i>FGFR1</i> Reduces Cerebellar Inflammation and Neurodegeneration in MOG<sub>35-55</sub>-Induced EAERanjithkumar Rajendran, Vinothkumar Rajendran, Mario Giraldo-Velasquez, et al.
Frontiers in Cardiovascular Medicine|May 6, 2022
Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' SerumSrikanth Karnati, Gulcan Guntas, Ranjithkumar Rajendran, et al.
Frontiers in Molecular Medicine|August 1, 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathyMalte Hachmann, Güntas Gülcan, Ranjithkumar Rajendran, et al.
British Journal of Pharmacology|October 5, 2024
Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosisFynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Brain Pathology (Zurich, Switzerland)|January 25, 2017
Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylationRanjithkumar Rajendran, Mario Giraldo-Velásquez, Christine Stadelmann, et al.
Cells|April 30, 2021
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease ModelsRanjithkumar Rajendran, Gregor Böttiger, Christine Stadelmann, et al.
Journal of Clinical Medicine|August 7, 2021
Evidence of a Muscle-Brain Axis by Quantification of the Neurotrophic Myokine METRNL (Meteorin-Like Protein) in Human Cerebrospinal Fluid and SerumMartin Berghoff, Alexandra Höpfinger, Ranjithkumar Rajendran, et al.
Brain Pathology (Zurich, Switzerland)|October 26, 2020
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG<sub>35-55</sub> -induced EAE through ERK and Akt signallingSalar Kamali, Ranjithkumar Rajendran, Christine Stadelmann, et al.
International Journal of Molecular Sciences|October 27, 2022
Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune EncephalomyelitisRanjithkumar Rajendran, Vinothkumar Rajendran, Liza Gupta, et al.
Cells|June 2, 2021
Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 OligodendrocytesRanjithkumar Rajendran, Gregor Böttiger, Niklas Dentzien, et al.
International Journal of Molecular Sciences|September 10, 2021
Oligodendrocyte-Specific Deletion of <i>FGFR1</i> Reduces Cerebellar Inflammation and Neurodegeneration in MOG<sub>35-55</sub>-Induced EAERanjithkumar Rajendran, Vinothkumar Rajendran, Mario Giraldo-Velasquez, et al.
Frontiers in Cardiovascular Medicine|May 6, 2022
Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' SerumSrikanth Karnati, Gulcan Guntas, Ranjithkumar Rajendran, et al.
Frontiers in Molecular Medicine|August 1, 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathyMalte Hachmann, Güntas Gülcan, Ranjithkumar Rajendran, et al.
British Journal of Pharmacology|October 5, 2024
Anti-inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosisFynn Gurski, Kian Shirvanchi, Vinothkumar Rajendran, et al.
Pageof 2